Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-02-07

FDA Approved: BUPROPION HYDROCHLORIDE — Supplemental Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Bupropion hydrochloride from Heritage Pharmaceuticals (d/b/a Avet Pharmaceuticals Inc.), representing regulatory…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bupropion hydrochloride (Bupropion hydrochloride)

Snippet

SUPPL AP for BUPROPION HYDROCHLORIDE (BUPROPION HYDROCHLORIDE)